A systematic review of interventions to improve adherence to statin medication: What do we know about what works?

被引:27
|
作者
Rash, Joshua A. [1 ]
Campbell, David J. T. [2 ,3 ]
Tonelli, Marcello [2 ,3 ]
Campbell, Tavis S. [1 ]
机构
[1] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Cumming Sch Med, Dept Med, 3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada
[3] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, 3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada
关键词
Statin; Lipid lowering medication; Adherence; Compliance; Persistence; Randomized controlled trials; Systematic review; Meta-analysis; RANDOMIZED CONTROLLED-TRIAL; PHARMACEUTICAL CARE PROGRAM; CORONARY-HEART-DISEASE; LONG-TERM ADHERENCE; RISK-FACTOR CONTROL; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; SECONDARY PREVENTION; PATIENT ADHERENCE; ELDERLY-PATIENTS;
D O I
10.1016/j.ypmed.2016.07.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Suboptimal adherence to statin medication is common and leads to serious negative health consequences but may respond to intervention. This review evaluated the effectiveness of interventions intended to improve adherence to statin medication. Data sources included peer-reviewed publications from Cochrane Register of Randomized Controlled Trials (RCTs), PubMed, CINAHL, and EMBase indexed between 01 October 2008 and 18 October 2015 and studies from reference lists and technical experts. RCTs that evaluated an intervention targeting adherence to self-administered statin medication for primary or secondary prevention were eligible. Two investigators independently reviewed trials, extracted data, and evaluated risk of bias. Twenty-nine RCTs reporting on 39,769 patients met inclusion. Identified RCTs exhibited methodological weaknesses: all but one failed to set inclusion parameters for medication adherence; nearly half lacked sufficient power to detect meaningful effects; and the majority had a risk of bias. Interventions were categorized into five classes (simplification of regimen, prescription cost coverage, reminders, education and information, and multi-faceted) and effects were pooled within each class. Prescription cost coverage, Hedges' g = 0.15, 95% CI [0.11: 0.21], simplification of drug regimen, Hedges' g = 0.38, 95% CI [0.22:0.55], the provision of education, Hedges' g = 0.19, 95% CI [0.01:0.37], and the use of multi-faceted interventions, Hedges' g=0.16, 95% CI [0.05:0.27], had small positive effects on statin adherence relative to usual care and reminders were promising, Hedges' g = 0.0.27, 95% CI [-0.05:0.60]. In conclusion, there are some successful interventions to improve adherence to statin medication but the effects are small and additional methodologically rigorous trials are needed. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:155 / 169
页数:15
相关论文
共 50 条
  • [41] What do we know about adherence and self-care?
    Evangelista, Lorraine S.
    Shinnick, Mary Ann
    [J]. JOURNAL OF CARDIOVASCULAR NURSING, 2008, 23 (03) : 250 - 257
  • [42] What We Know and What We Do Not Know about Dragon Trees?
    Madera, Petr
    Forrest, Alan
    Hanacek, Pavel
    Vahalik, Petr
    Gebauer, Roman
    Plichta, Roman
    Jupa, Radek
    Van Rensburg, Julian Jansen
    Morris, Miranda
    Nadezhdina, Nadezhda
    Vanickova, Lucie
    Jura-Morawiec, Joanna
    Wiland-Szymanska, Justyna
    Kalivodova, Hana
    Lengalova, Klara
    Rejzek, Martin
    Habrova, Hana
    [J]. FORESTS, 2020, 11 (02):
  • [43] What do we (not) know about how paracetamol (acetaminophen) works?
    Toussaint, K.
    Yang, X. C.
    Zielinski, M. A.
    Reigle, K. L.
    Sacavage, S. D.
    Nagar, S.
    Raffa, R. B.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 617 - 638
  • [44] What we Know, What We Do Not Know, and What We May Know Soon About Interventions for Treatment Resistant Depression in Late-Life?
    Roose, Steven P.
    Brown, Patrick J.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (05): : 557 - 559
  • [45] What Do We Really Know about the Effectiveness of Glaucoma Interventions? An Overview of Systematic Reviews
    Qureshi, Riaz
    Azuara-Blanco, Augusto
    Michelessi, Manuele
    Virgili, Gianni
    Cutolo, Carlo Alberto
    Pazos, Marta
    Katsanos, Andreas
    Garhofer, Gerhard
    Kolko, Miriam
    Prokosch-Willing, Verena
    Al Rajhi, Ali Ahmed
    Lum, Flora
    Musch, David
    Gedde, Steven
    Li, Tianjing
    [J]. OPHTHALMOLOGY GLAUCOMA, 2021, 4 (05): : 454 - 462
  • [46] What do we know about preventing school violence? A systematic review of systematic reviews
    Lester, Soraya
    Lawrence, Cayleigh
    Ward, Catherine L.
    [J]. PSYCHOLOGY HEALTH & MEDICINE, 2017, 22 : 187 - 223
  • [47] Do we do what we know works, and if not why not?
    Goldney, Robert D.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 (10): : 907 - 908
  • [48] Do we do what we know works, and if not why not?
    Killackey, Eoin
    Jorm, Anthony
    Alvarez-Jimenez, Mario
    McCann, Terence V.
    Hides, Leanne
    Couineau, Anne-Laure
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 (06): : 439 - 444
  • [49] What do we know about why women bleed and what do we not know?
    James, Andra H.
    James, Paula D.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (02) : 315 - 322
  • [50] Atrial fibrillation: what do we know about screening and what do we not know about treatment?
    Pokorney, Sean D.
    Lopes, Renato D.
    [J]. HEART, 2019, 105 (11) : 817 - 819